These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Use of monoclonal antibodies in prophylaxis and treatment of acute and chronic graft-versus-host disease in 2011]. Xhaard A; Hermet E; Bay JO; Peffault de Latour R Bull Cancer; 2011 Aug; 98(8):889-99. PubMed ID: 21835730 [TBL] [Abstract][Full Text] [Related]
11. [Vedolizumab for treatment of steroid-refractory intestinal acute graft-versus-host disease: two cases report and literature review]. Gao SC; Feng YM; Gao L; Kong PY; Zhu LD; Liu J; Wang L; Liu HF; Zhang X Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1046-1049. PubMed ID: 36709113 [No Abstract] [Full Text] [Related]
15. Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation. Zhao Y; Shi J; Luo Y; Gao F; Tan Y; Lai X; Yu J; Wei G; Huang H Biol Blood Marrow Transplant; 2020 May; 26(5):e128-e133. PubMed ID: 31982545 [TBL] [Abstract][Full Text] [Related]
16. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease. Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252 [TBL] [Abstract][Full Text] [Related]
17. The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review. Ali AM; DiPersio JF; Schroeder MA Biol Blood Marrow Transplant; 2016 Sep; 22(9):1552-1564. PubMed ID: 27158050 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease. Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Borjas-Almaguer OD; González-Llano O; Jaime-Pérez JC; Solano-Genesta M; Gómez-Guijosa M; Mancias-Guerra C; Tarin L; Gómez-Almaguer D Haematologica; 2012 May; 97(5):717-22. PubMed ID: 22133770 [TBL] [Abstract][Full Text] [Related]
19. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation. Iliopoulou BP; Hsu K; Pérez-Cruz M; Tang SW; Pang WW; Erkers T; Kambham N; Freeman GJ; Dekruyff RH; Meyer EH Blood Adv; 2019 Nov; 3(21):3419-3431. PubMed ID: 31714958 [TBL] [Abstract][Full Text] [Related]
20. Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease. Danylesko I; Bukauskas A; Paulson M; Peceliunas V; Gedde-Dahl D Y T; Shimoni A; Shouval R; Griskevicius L; Floisand Y; Nagler A Bone Marrow Transplant; 2019 Jul; 54(7):987-993. PubMed ID: 30356163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]